The invention relates to an agent specific for peripheral sensory afferents. The agent may inhibit the transmission of signals between a primary sensory afferent and a projection neutron by controlling the release of at least one neurotransmitter or neuromodulator from the primary sensory afferent. The agent may be used in or as a pharmaceutical for the treatment of pain, particularly chronic pain.

 
Web www.patentalert.com

< External addition of pulses to fluid channels of body to release or suppress endothelial mediators and to determine effectiveness of such intervention

< Inhalation nebulizer

> Method for reducing the inflammation and inducing an analgesic effect and compounds thereof

> Pyrrolopyrimidinone derivatives, process of preparation and use
~ 00221